Burning Rock Biotech Limited Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Burning Rock Biotech Limited (BNR) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-04-28
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-04-28 |
| 2024-12-31 | $0.00 20-F · filed 2025-04-29 |
| 2023-12-31 | $0.00 20-F · filed 2024-04-29 |
| 2022-12-31 | $7.39 20-F · filed 2023-04-20 |
| 2021-12-31 | $0.00 20-F · filed 2023-04-20 |
| 2020-12-31 | $0.00 20-F · filed 2023-04-20 |
| 2019-12-31 | $2.90 20-F · filed 2022-04-29 |
| 2018-12-31 | $0.00 20-F · filed 2021-03-23 |